Ketamine Addiction in Pakistan: Signs, Effects, and Treatment

Ketamine occupies an unusual position in Pakistan’s drug landscape. It is a legitimate pharmaceutical compound with genuine medical applications, a dissociative anaesthetic used in hospitals and veterinary settings worldwide. It is also, increasingly, a drug of abuse in Pakistani urban centres, where it circulates in party and social environments under names like Special K, Ket, and Vitamin K.

Awareness of ketamine as a drug problem in Pakistan lags behind its actual prevalence. Families encountering it often have no reference point. Clinicians who trained in an era when ketamine abuse was rare are seeing it more frequently. And users themselves often underestimate its addiction potential, partly because of its medical legitimacy and partly because the dependency it produces looks different from the dependency associated with heroin or alcohol.

This blog explains what ketamine is, how it affects the brain and body, what ketamine addiction looks like, and what treatment involves.

What is ketamine?

Ketamine is a dissociative anaesthetic developed in the 1960s and still used in legitimate medical practice as an anaesthetic agent, particularly in emergency and paediatric settings, and more recently in low doses as a treatment for treatment-resistant depression under close clinical supervision. It is listed on the World Health Organization’s List of Essential Medicines for its anaesthetic applications.

As a drug of abuse, ketamine is most commonly found as a white powder, a clear liquid, or pressed into tablets. It is typically snorted, though it can also be swallowed or injected. The effects depend significantly on the dose. At low doses it produces mild dissociation, euphoria, and perceptual distortions. At higher doses it produces a profound dissociative state commonly called the K-hole, in which the user experiences near-complete detachment from their body and surroundings, a state of sensory isolation that some users find intensely pleasurable and others find terrifying.

The drug acts primarily on NMDA receptors, a type of glutamate receptor involved in memory, learning, and pain perception. By blocking these receptors, ketamine disrupts normal brain function and produces its dissociative effects.

In Pakistan, ketamine is primarily available through diversion from pharmaceutical and veterinary supply chains. Its availability has grown alongside the broader increase in synthetic and pharmaceutical drug abuse in urban centres.

How ketamine affects the brain and body

Ketamine’s mechanism of action is distinct from that of opioids, stimulants, or cannabis. Its primary target is the glutamate system rather than the dopamine or opioid systems, which gives ketamine abuse a different neurological profile from most other commonly abused substances.

Immediate effects

At recreational doses, ketamine produces dissociation from the environment and from the self, distorted perception of time and space, euphoria or a dreamlike detached state, visual and auditory distortions, and impaired coordination and movement. The onset is rapid and the duration relatively short compared to many other substances, typically lasting 45 minutes to two hours depending on dose and route of administration.

At very high doses, the K-hole experience involves near-complete dissociation and is described by users variously as transcendent or deeply disturbing. Users in the K-hole are essentially incapacitated and are at significant risk of physical harm from their environment, as they cannot respond normally to danger.

Effects on memory

Even at recreational doses, ketamine significantly impairs episodic memory. Blackouts and memory gaps during use are common. With sustained heavy use, ketamine causes lasting damage to memory function that extends well beyond the period of intoxication and that does not fully reverse with abstinence in heavy users.

Ketamine bladder syndrome

This is the most serious and distinctive physical consequence of heavy ketamine use and one that is increasingly common in heavy users presenting to treatment. Ketamine and its metabolites are toxic to the urinary tract. Heavy, sustained use causes progressive inflammatory damage to the bladder wall, producing a condition characterised by severe and constant urinary urgency and frequency, significant pelvic pain, reduced bladder capacity, and in severe cases bladder shrinkage requiring surgical intervention.

Research published in BJU International documented ketamine-associated uropathy as an emerging clinical concern among heavy users. The condition is partially reversible in early stages with abstinence, but advanced cases may require ongoing urological management regardless of whether the person stops using. This complication is a significant source of suffering in heavy ketamine users and is often the presenting complaint that finally prompts them to seek help.

Cardiovascular effects

Ketamine increases heart rate and blood pressure during use. For people with pre-existing cardiovascular conditions, this carries meaningful risk.

Cognitive effects

Beyond memory impairment, sustained heavy ketamine use is associated with significant impairment in attention, processing speed, and executive function. These effects are dose-dependent and accumulate with continued use. Some degree of cognitive recovery occurs with sustained abstinence, but heavy long-term users often retain measurable cognitive deficits.

Psychological effects

Anxiety, depression, and the onset or worsening of psychotic symptoms are all associated with sustained ketamine use. The dissociative effects of the drug can blur into persistent dissociative symptoms in heavy users, producing a state of chronic mild dissociation from reality that interferes significantly with normal functioning.

Does ketamine cause addiction?

This question is asked frequently and deserves a direct answer. Yes, ketamine causes addiction, though the nature of the dependency is primarily psychological rather than physical in the way that alcohol or heroin dependency is physical.

Ketamine does not produce the same intense physical withdrawal syndrome as opioids or alcohol. This is one of the reasons its addiction potential is underestimated. Users who stop taking ketamine do not typically experience the severe physical withdrawal that characterises heroin or alcohol cessation. What they do experience is profound psychological craving, an inability to feel pleasure or emotional equilibrium without the drug, anxiety, depression, cognitive disturbance, and a powerful pull back toward use.

The absence of dramatic physical withdrawal does not make ketamine addiction less real or less serious. Psychological dependency is a genuine and often tenacious form of addiction, and the cognitive and psychiatric consequences of sustained ketamine use make it clinically significant regardless of the physical withdrawal picture.

The United Nations Office on Drugs and Crime recognises ketamine as a substance of abuse with dependence potential, noting that its use has expanded significantly in East and South-East Asia and is increasingly appearing in South Asian markets including Pakistan.

Signs of ketamine addiction

Because ketamine addiction does not follow the pattern most families associate with serious drug dependency, the signs are sometimes missed or misattributed.

Escalating use. The person uses ketamine more frequently and in larger quantities over time. What began as occasional recreational use has become regular, then daily.

Psychological preoccupation. The person spends significant mental energy thinking about ketamine, anticipating their next use, and arranging access to the drug. Their interest in activities and relationships outside of ketamine use diminishes.

Using it to manage psychological states. The person uses ketamine to manage anxiety, low mood, stress, or feelings of emptiness rather than for recreational enjoyment. The drug has become a coping mechanism rather than an occasional pleasure.

Cognitive changes. Memory problems, difficulty concentrating, slowed thinking, and an increasingly vague or detached presentation are all noticed by family and colleagues before the person acknowledges them.

Dissociative symptoms between uses. Heavy users sometimes experience mild dissociative symptoms even when they have not recently used, including a sense of unreality, depersonalisation, or emotional detachment from their surroundings and relationships.

Physical symptoms of bladder damage. Complaints of urinary urgency, frequency, pelvic pain, or difficulty urinating in a young person with no other obvious cause should raise the question of ketamine use in the clinical assessment.

Secrecy and social withdrawal. The person becomes secretive about their activities, withdraws from family relationships, and gravitates toward a social circle centred around drug use.

Inability to stop despite wanting to. Attempts to reduce or stop use consistently fail. The person may have insight into the harm their use is causing while being unable to act on that insight.

Ketamine in Pakistan’s social landscape

Ketamine abuse in Pakistan is not yet at the scale of heroin or cannabis addiction in terms of numbers, but its growth trajectory warrants serious attention. It is concentrated primarily in urban centres, in younger adults with access to nightlife environments or social networks in which drug experimentation is normalised, and in groups where pharmaceutical drug availability is higher.

Its medical legitimacy makes it harder for families and even some clinicians to take it seriously as a drug of abuse. The perception that a drug used in hospitals cannot be genuinely dangerous when used recreationally is a significant barrier to recognition and treatment-seeking.

The absence of a dramatic physical withdrawal syndrome means that the transition from recreational use to addiction can occur gradually and without the obvious crisis points that often prompt families to seek help with heroin or alcohol. By the time the cognitive changes, urological symptoms, or psychiatric consequences become apparent, the addiction is often well-established.

Treatment for ketamine addiction

Treatment for ketamine addiction follows the general framework for substance use disorders, adapted for the specific characteristics of ketamine dependency — primarily psychological rather than physical, with significant cognitive and psychiatric dimensions.

Clinical assessment is the essential starting point. A thorough assessment establishes the pattern and severity of use, documents any physical complications particularly urological symptoms, assesses cognitive function, and identifies any co-occurring psychiatric conditions. For patients with bladder symptoms, urological referral is a clinical priority alongside addiction treatment.

Medical management during the initial period of abstinence focuses on managing the psychological symptoms of stopping rather than a dramatic physical withdrawal syndrome. Anxiety, depression, sleep disturbance, and in some cases dissociative symptoms all warrant clinical attention. Appropriate medication support under psychiatric supervision can significantly ease the early period of abstinence.

Residential rehabilitation provides the structured, drug-free environment that ketamine recovery requires. The psychological pull of the drug is significant, and the environments and social networks associated with use are powerful relapse triggers. A period of residential care away from those triggers, while the psychological and cognitive effects of ketamine use begin to resolve, gives recovery the foundation it needs. Our Drug Addiction Treatment Program offers 30, 60, and 90-day residential options.

Cognitive Behavioural Therapy addresses the thought patterns, emotional regulation deficits, and behavioural habits that drive ketamine use. For many users, ketamine has become the primary tool for managing anxiety, low mood, or a chronic sense of detachment from life. CBT works to develop alternative strategies for managing these states and to address the underlying vulnerabilities that the drug has been used to cope with.

Dual diagnosis treatment is relevant for a significant proportion of ketamine users, because depression, anxiety, and dissociative symptoms frequently co-occur with ketamine addiction and require concurrent clinical management. Our Dual Diagnosis Program provides integrated psychiatric and psychological treatment within the rehabilitation process. This is particularly important for ketamine because the psychiatric consequences of sustained use can mimic and exacerbate primary mental health conditions.

Cognitive rehabilitation is an underappreciated component of ketamine recovery. The memory and cognitive impairments associated with heavy ketamine use do not resolve immediately with abstinence. Structured cognitive support and rehabilitation, combined with sustained abstinence, gives the brain the best conditions for recovery.

Family involvement through our Family Support Program supports families in understanding ketamine addiction, recognising the specific signs, and providing the kind of consistent and informed support that promotes recovery rather than inadvertently enabling continued use.

When to seek help

If you are concerned about your own ketamine use or that of someone close to you, the right time to seek help is now, before the cognitive, psychiatric, and urological consequences of sustained use become more established.

Ketamine addiction is treatable. The cognitive and psychiatric consequences of use are partially reversible with sustained abstinence and appropriate support. The urological consequences are most amenable to recovery when abstinence begins early. Waiting for the problem to resolve on its own is not a viable strategy. The nature of the addiction is that without intervention, use escalates and consequences accumulate.

Contact us today for a confidential assessment, WhatsApp us to reach out privately, or call us to speak with a member of our clinical team directly.